Cargando…

LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells

(−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Tingyu, Han, Di, Xu, Yong, Peng, Wenpan, Bai, Le, Zhou, Xianmei, He, Hailang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505700/
https://www.ncbi.nlm.nih.gov/pubmed/34650434
http://dx.doi.org/10.3389/fphar.2021.732716
_version_ 1784581589195292672
author Pan, Tingyu
Han, Di
Xu, Yong
Peng, Wenpan
Bai, Le
Zhou, Xianmei
He, Hailang
author_facet Pan, Tingyu
Han, Di
Xu, Yong
Peng, Wenpan
Bai, Le
Zhou, Xianmei
He, Hailang
author_sort Pan, Tingyu
collection PubMed
description (−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the metabolite changes in A549 cells induced by EGCG in vitro utilizing liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. The result revealed 33 differentially expressed metabolites between untreated and 80 μM EGCG-treated A549 cells. The altered metabolites were involved in the metabolism of glucose, amino acid, nucleotide, glutathione, and vitamin. Two markedly altered pathways, including glycine, serine and threonine metabolism and alanine, aspartate and glutamate metabolism, were identified by MetaboAnalyst 5.0 metabolic pathway analysis. These results may provide potential clues for the intramolecular mechanisms of EGCG’s effect on A549 cells. Our study may contribute to future molecular mechanistic studies of EGCG and the therapeutic application of EGCG in cancer management.
format Online
Article
Text
id pubmed-8505700
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85057002021-10-13 LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells Pan, Tingyu Han, Di Xu, Yong Peng, Wenpan Bai, Le Zhou, Xianmei He, Hailang Front Pharmacol Pharmacology (−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the metabolite changes in A549 cells induced by EGCG in vitro utilizing liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. The result revealed 33 differentially expressed metabolites between untreated and 80 μM EGCG-treated A549 cells. The altered metabolites were involved in the metabolism of glucose, amino acid, nucleotide, glutathione, and vitamin. Two markedly altered pathways, including glycine, serine and threonine metabolism and alanine, aspartate and glutamate metabolism, were identified by MetaboAnalyst 5.0 metabolic pathway analysis. These results may provide potential clues for the intramolecular mechanisms of EGCG’s effect on A549 cells. Our study may contribute to future molecular mechanistic studies of EGCG and the therapeutic application of EGCG in cancer management. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8505700/ /pubmed/34650434 http://dx.doi.org/10.3389/fphar.2021.732716 Text en Copyright © 2021 Pan, Han, Xu, Peng, Bai, Zhou and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pan, Tingyu
Han, Di
Xu, Yong
Peng, Wenpan
Bai, Le
Zhou, Xianmei
He, Hailang
LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title_full LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title_fullStr LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title_full_unstemmed LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title_short LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
title_sort lc–ms based metabolomics study of the effects of egcg on a549 cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505700/
https://www.ncbi.nlm.nih.gov/pubmed/34650434
http://dx.doi.org/10.3389/fphar.2021.732716
work_keys_str_mv AT pantingyu lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT handi lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT xuyong lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT pengwenpan lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT baile lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT zhouxianmei lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells
AT hehailang lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells